German  |  English
Features for this Premium Statistic
 
Download als JPG Download JPG
Download JPG Download Powerpoint
Download als Excel-Statistik Download Excel
Print Print
Add To Favorites Add To Favorites
Do you have a question or a suggestion for this statistic? Please visit our contact page.
More statistics about...
 
You may also be interested in...
 
Top Topics
 
Photo: istockphoto.com / alekup

HIV/AIDS worldwide

Photo: sxc.hu / lockstockb

Health

More on Health & Pharmaceuticals

Show all topics
We are celebrating
 
International Year of Statistics 2013Statistics have powerful and far-reaching effects on everyone, yet most people are unaware of their connection and how statistics improve their lives. 2013 is the International Year of Statistics, a worldwide event supported by nearly 1,900 organizations - and we are part of it!learn more
Recommended Websites
 

Do you know of an interesting website related to this topic? Suggest here

Most popular questions
 

Boehringer Ingelheim's expenditure on research and development 2004-2012 (fee-based)

Boehringer Ingelheim's expenditure on research and development from 2004 to 2012 (in million euros)

Do you want to view this graph? Sign up for a Premium Account and benefit from the following extras:

  • Quick and convenient access to all statistics
  • More than 1.5 million statistics and facts
  • All data downloadable in PPT, XLS and JPG format

Get Account Source Get Account


© Statista 2013

Reading support:
This statistic describes the expenditure on research and development by pharmaceutical company Boehringer Ingelheim from 2004 to 2012. In 2005, the company invested almost 1.4 billion euros in research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.

Statistic Information
 
close Markets and sectors
Health & Pharmaceuticals , Medicine & Pharmaceuticals
Survey
Survey by  Get Account
Survey name  Get Account
Survey time period 2004 to 2012
Object of investigation Boehringer Ingelheim's research and development expenditure
Region Worldwide
Macroregion Trans-Continental only (with GER)
Type time series
Category business company, production/equipment
Relevance 3
Release
Published by  Get Account
Source link  Get Account
Release date April 2013
Cataloging
Tags Boehringer Ingelheim, Boehringer Ingelheim Pharma, development, drug, drug manufacturers, expenditure, expenses, medicine, Pharma Industry, pharmaceutical companies, Pharmaceutical companies, pharmaceutical company, pharmaceutical industry, Pharmaceuticals, R & D, R&D, R&D, Research, Research and Development, spending, total expenses, total expenses
Top tags drug, expenditure, R&D, Pharmaceuticals, Boehringer Ingelheim
Markets and sectors Health & Pharmaceuticals, Medicine & Pharmaceuticals
Further information  Get Account
Popular statistics
 
Viewed by other users
 
Latest statistics
 
Related reports
 
to: drug, expenditure, R&D, Pharmaceuticals, Boehringer Ingelheim
Top statistics from the category: Health & Pharmaceuticals

Health & Pharmaceuticals

More on Health & Pharmaceuticals

Medicine & Pharmaceuticals

More on Medicine & Pharmaceuticals

How you can access Statista